Skip to Main Content (Press Enter)
×
Home
Persone
Strutture
Competenze
Pubblicazioni
Professioni
Corsi
Insegnamenti
Terza Missione
IT
EN
☰
Competenze & Professionalità
|
Competenze & Professionalità
unibs.it
IT
EN
×
Home
Persone
Strutture
Competenze
Pubblicazioni
Professioni
Corsi
Insegnamenti
Terza Missione
☰
Pubblicazioni
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Rivista
Codice:
E090470
ISSN:
0305-7453
Dati Generali
Dati Generali
Pubblicazioni (46)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
"Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study
Articolo
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
Articolo
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study
Articolo
Atazanavir and darunavir in pregnant women with HIV: Evaluation of laboratory and clinical outcomes from an observational national study
Articolo
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients
Articolo
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial
Articolo
Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy
Articolo
CD4+ T cell evolution and predictors of its trend before and aftertenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load
Articolo
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis
Articolo
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study
Articolo
Distribution of K103N and/or Y181C HIV-1 mutations by exposure to zidovudine and non-nucleoside reverse transcriptase inhibitors
Articolo
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL
Articolo
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting
Articolo
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy
Articolo
Efficacy and safety of a switch to unboosted atazanavir incombination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy
Articolo
Erratum: Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study [J Antimicrob Chemother, 72, (2017) (2879-2886)] DOI: 10.1093/jac/dkx169
Articolo
Esomeprazole versus omeprazole. Antimicrobial activity in vitro against Helicobacter pylori
Articolo
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry
Articolo
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial
Articolo
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort.
Articolo
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations
Articolo
In-vitro activity of cefotetan and other cephalosporins on Klebsiella and resistance to inactivating bacterial enzymes
Articolo
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort
Articolo
Intramuscolar meropenem in the tratment of bacterial infections of the urinary and lower respiratory tracts. Italian Intramuscolar Meropenem Study Group.
Articolo
Key Questions in antiretroviral therapy: Italian Consensus Workshop (2005)
Articolo
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus
Articolo
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study
Articolo
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort
Articolo
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy
Articolo
Lopinavir pharmacokinetic profiles in HIV-infected patients during rifabutin-based anti-mycobacterial therapy
Articolo
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: A MASTER cohort study
Articolo
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era
Articolo
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry
Articolo
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: A sub-study of the NEAT001/ANRS143 randomized trial
Articolo
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART
Articolo
Recent changes in bacterial epidemiology and the emergence offluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
Articolo
Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso
Articolo
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy
Articolo
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)
Articolo
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART
Articolo
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry
Articolo
Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis
Articolo
Use of linezolid in infants and children: a retrospective multicentre study of the Italian Society for Paediatric Infectious Diseases.
Articolo
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry
Articolo
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts
Articolo
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
